IL108247A - תכשירי רוקחות המכילים 0-אריל אתרים דקסטרורוטטוריים של מורפינאנים להפחתת השפעות מזי קות של פגיעה נוירוטוקסית תרכבות מסו - Google Patents
תכשירי רוקחות המכילים 0-אריל אתרים דקסטרורוטטוריים של מורפינאנים להפחתת השפעות מזי קות של פגיעה נוירוטוקסית תרכבות מסוInfo
- Publication number
- IL108247A IL108247A IL108247A IL10824793A IL108247A IL 108247 A IL108247 A IL 108247A IL 108247 A IL108247 A IL 108247A IL 10824793 A IL10824793 A IL 10824793A IL 108247 A IL108247 A IL 108247A
- Authority
- IL
- Israel
- Prior art keywords
- formula
- morphinan
- methyl
- oxy
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/22—Bridged ring systems
- C07D221/28—Morphinans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US113593A | 1993-01-06 | 1993-01-06 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL108247A0 IL108247A0 (en) | 1994-04-12 |
| IL108247A true IL108247A (he) | 1998-02-22 |
Family
ID=21694554
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL108247A IL108247A (he) | 1993-01-06 | 1993-12-31 | תכשירי רוקחות המכילים 0-אריל אתרים דקסטרורוטטוריים של מורפינאנים להפחתת השפעות מזי קות של פגיעה נוירוטוקסית תרכבות מסו |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP0612730B1 (he) |
| JP (1) | JP2501298B2 (he) |
| KR (1) | KR940018094A (he) |
| CN (1) | CN1097006A (he) |
| AT (1) | ATE154931T1 (he) |
| AU (1) | AU681601B2 (he) |
| BR (1) | BR9400021A (he) |
| CA (1) | CA2110337A1 (he) |
| CZ (1) | CZ2294A3 (he) |
| DE (1) | DE69311887T2 (he) |
| DK (1) | DK0612730T3 (he) |
| ES (1) | ES2105061T3 (he) |
| FI (1) | FI940041A (he) |
| GR (1) | GR3024891T3 (he) |
| HU (2) | HUT66061A (he) |
| IL (1) | IL108247A (he) |
| MX (1) | MX9400177A (he) |
| NO (1) | NO940028D0 (he) |
| NZ (1) | NZ250580A (he) |
| PL (1) | PL175365B1 (he) |
| TW (1) | TW264473B (he) |
| UY (1) | UY23706A1 (he) |
| ZA (1) | ZA939806B (he) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9522176D0 (en) * | 1995-10-30 | 1996-01-03 | Iaf Biochem Int | Morphinan derivatives having neuroprotective activity |
| EP0812827B1 (en) * | 1996-06-13 | 2009-09-02 | Sumitomo Chemical Company, Limited | Piperidine derivative as intermediates for the preparation of paroxetine and process for their preparation |
| FR2752163B1 (fr) * | 1996-08-12 | 1998-10-30 | Pf Medicament | Utilisation de l'efaroxan pour la fabricaton de medicament destine au traitement de la maladie de huntington |
| GB9706753D0 (en) * | 1997-04-03 | 1997-05-21 | Pharmacia & Upjohn Spa | Aralkoxy-morphinan derivatives |
| KR100425881B1 (ko) * | 2001-03-14 | 2004-04-03 | 고광호 | 신규한 몰피난 유도체 |
| MXPA04011327A (es) * | 2002-05-17 | 2005-08-15 | Jenken Biosciences Inc | Opioides y compuestos similares a opioides y usos de los mismos. |
| DE10229842A1 (de) * | 2002-07-03 | 2004-02-05 | Helmut Prof. Dr. Schmidhammer | Morphinanderivate und deren quartäre Ammoniumsalze substituiert in Position 14, Herstellungsverfahren und Verwendung |
| US20040204862A1 (en) | 2003-04-11 | 2004-10-14 | Wainer Irving W. | Computer-based model for identification and characterization for non-competitive inhibitors of nicotinic acetylcholine receptors and related ligand-gated ion channel receptors |
| US8017622B2 (en) | 2003-05-16 | 2011-09-13 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
| JP5784507B2 (ja) * | 2009-02-23 | 2015-09-24 | マリンクロッド エルエルシー | （＋）−モルフィナニウム第四級塩およびその生成方法 |
| CN103044327B (zh) * | 2013-01-07 | 2014-12-17 | 苏州立新制药有限公司 | 一种右美沙芬的制备方法 |
| CN117427077A (zh) * | 2014-09-14 | 2024-01-23 | 阿瓦尼尔制药股份有限公司 | 用于治疗痴呆中的激越行为的包含右美沙芬化合物和奎尼丁的药物组合物 |
| WO2016138103A1 (en) * | 2015-02-25 | 2016-09-01 | Alkermes, Inc. | Treatments for alzheimer's related diseases and disorders |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI773636A (fi) * | 1976-12-06 | 1978-06-07 | Hoffmann La Roche | Nya fenylderivat |
| US4113729A (en) * | 1976-12-06 | 1978-09-12 | Hoffmann-La Roche Inc. | 3-Phenoxymorphinans and derivatives thereof |
| US4806543A (en) * | 1986-11-25 | 1989-02-21 | Board Of Trustees Of The Leland Stanford Junior University | Method and compositions for reducing neurotoxic injury |
-
1993
- 1993-11-25 TW TW082109942A patent/TW264473B/zh active
- 1993-11-30 CA CA002110337A patent/CA2110337A1/en not_active Abandoned
- 1993-12-20 DE DE69311887T patent/DE69311887T2/de not_active Expired - Fee Related
- 1993-12-20 EP EP93120498A patent/EP0612730B1/en not_active Expired - Lifetime
- 1993-12-20 ES ES93120498T patent/ES2105061T3/es not_active Expired - Lifetime
- 1993-12-20 AT AT93120498T patent/ATE154931T1/de not_active IP Right Cessation
- 1993-12-20 DK DK93120498.6T patent/DK0612730T3/da active
- 1993-12-23 NZ NZ250580A patent/NZ250580A/en unknown
- 1993-12-30 ZA ZA939806A patent/ZA939806B/xx unknown
- 1993-12-30 JP JP5354172A patent/JP2501298B2/ja not_active Expired - Lifetime
- 1993-12-31 AU AU52807/93A patent/AU681601B2/en not_active Ceased
- 1993-12-31 IL IL108247A patent/IL108247A/he not_active IP Right Cessation
- 1993-12-31 UY UY23706A patent/UY23706A1/es unknown
-
1994
- 1994-01-03 HU HU9400002A patent/HUT66061A/hu unknown
- 1994-01-03 MX MX9400177A patent/MX9400177A/es not_active IP Right Cessation
- 1994-01-04 KR KR1019940000067A patent/KR940018094A/ko not_active Application Discontinuation
- 1994-01-04 NO NO940028A patent/NO940028D0/no unknown
- 1994-01-05 CN CN94100181A patent/CN1097006A/zh active Pending
- 1994-01-05 CZ CZ9422A patent/CZ2294A3/cs unknown
- 1994-01-05 PL PL94301784A patent/PL175365B1/pl unknown
- 1994-01-05 BR BR9400021A patent/BR9400021A/pt not_active Application Discontinuation
- 1994-01-05 FI FI940041A patent/FI940041A/fi unknown
-
1995
- 1995-06-19 HU HU95P/P00253P patent/HU211290A9/hu unknown
-
1997
- 1997-09-30 GR GR970402538T patent/GR3024891T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR940018094A (ko) | 1994-08-16 |
| NO940028L (he) | 1994-07-07 |
| JPH06316564A (ja) | 1994-11-15 |
| FI940041A (fi) | 1994-07-07 |
| NZ250580A (en) | 1996-07-26 |
| ZA939806B (en) | 1994-07-06 |
| PL175365B1 (pl) | 1998-12-31 |
| PL301784A1 (en) | 1994-07-11 |
| TW264473B (he) | 1995-12-01 |
| GR3024891T3 (en) | 1998-01-30 |
| HU9400002D0 (en) | 1994-05-30 |
| CA2110337A1 (en) | 1994-07-07 |
| MX9400177A (es) | 1994-07-29 |
| DE69311887D1 (de) | 1997-08-07 |
| HU211290A9 (en) | 1995-11-28 |
| EP0612730A1 (en) | 1994-08-31 |
| IL108247A0 (en) | 1994-04-12 |
| NO940028D0 (no) | 1994-01-04 |
| ES2105061T3 (es) | 1997-10-16 |
| CN1097006A (zh) | 1995-01-04 |
| BR9400021A (pt) | 1994-07-26 |
| EP0612730B1 (en) | 1997-07-02 |
| UY23706A1 (es) | 1994-06-05 |
| DE69311887T2 (de) | 1998-01-15 |
| HUT66061A (en) | 1994-09-28 |
| FI940041A0 (fi) | 1994-01-05 |
| DK0612730T3 (da) | 1998-02-02 |
| CZ2294A3 (en) | 1994-07-13 |
| AU681601B2 (en) | 1997-09-04 |
| ATE154931T1 (de) | 1997-07-15 |
| AU5280793A (en) | 1994-07-14 |
| JP2501298B2 (ja) | 1996-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5308854A (en) | Inhibitors of HIV reverse transcriptase | |
| CA2762680C (en) | Methyl sulfanyl pyrmidmes useful as antiinflammatories, analgesics, and antiepileptics | |
| FI96768B (fi) | Menetelmä valmistaa farmakologisesti arvokasta bentso/5,6/sykloheptapyridiiniä | |
| EP0170213B1 (en) | Glutarimide antianxiety and antihypertensive agents | |
| US6642228B1 (en) | α1b-adrenergic receptor antagonists | |
| UA55461C2 (uk) | 2-амінопіридини, які мають циклоконденсовані замісники, як інгібітори оксиду азоту синтази, фармацевтичні композиції, способи лікування або попередження хворобливих станів та спосіб інгібування оксиду азоту синтази | |
| JPH05140149A (ja) | 縮合複素環誘導体 | |
| US5614518A (en) | Morpholine derivatives as dopamine receptor subtype ligands | |
| EP0612730B1 (en) | O-aryl ethers of morphinans | |
| JPS6289679A (ja) | ピペリジン誘導体 | |
| DE69630604T2 (de) | Heterocyclylcarboxamid-derivate und ihre verwendung als therapeutische mittel | |
| EP0560235A1 (en) | Condensed heterocyclic ketone derivatives, their production and use | |
| BG61893B2 (bg) | Метаноантрацени като допаминови антагонисти | |
| JP2001512727A (ja) | ５ｈｔ−１受容体のリガンドとしてのニ環式化合物 | |
| JPH07503022A (ja) | ピリドン誘導体，その製造方法およびその医薬としての使用 | |
| US5935955A (en) | Pharmaceutical piperazine compounds | |
| US5849765A (en) | Tetrahydropyridine derivatives as dopamine receptor subtype ligands | |
| US4612312A (en) | Glutarimide antianxiety and antihypertensive agents | |
| EP2496579B1 (en) | 1-substituted 2-azabicyclo[3.1.1]heptyl derivatives useful as nicotinic acetylcholine receptor modulators for treating neurologic disorders | |
| HUT54151A (en) | Process fopr producing new (r)-(-)-3-quinuclidinone derivatives and pharmaceutical compositions comprising such compounds | |
| KR20000070756A (ko) | 동맥경화증 및 지단백질과잉혈증 치료에 사용되는 2-아미노 치환된 피리딘 | |
| US4448777A (en) | 1-Phenylindazole-3-one compounds, process and intermediates for their preparation, and pharmaceutical compositions containing same | |
| US5438062A (en) | Benzo(5,6)cycloheptapyridines, compositions and methods of use | |
| JPH0720933B2 (ja) | インダノピロリジンカルバメート | |
| RU2123000C1 (ru) | О-арильные эфиры морфинанов, фармацевтическая композиция |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| RH | Patent void |